AR010583A1 - CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN. - Google Patents

CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN.

Info

Publication number
AR010583A1
AR010583A1 ARP970105278A ARP970105278A AR010583A1 AR 010583 A1 AR010583 A1 AR 010583A1 AR P970105278 A ARP970105278 A AR P970105278A AR P970105278 A ARP970105278 A AR P970105278A AR 010583 A1 AR010583 A1 AR 010583A1
Authority
AR
Argentina
Prior art keywords
strain
cultivation
cells
composition
vaccine containing
Prior art date
Application number
ARP970105278A
Other languages
English (en)
Original Assignee
Pfizer
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR010583(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer, Univ Auburn filed Critical Pfizer
Publication of AR010583A1 publication Critical patent/AR010583A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Cultivos vivos atenuados del parásito protozoo patogeno neospora, y vacunas vivas contra la neosporosis preparadas con el mismo, que son utiles enla prevencion de enfermedad clínica y aborto en mamíferos.
ARP970105278A 1996-11-12 1997-11-12 CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN. AR010583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12

Publications (1)

Publication Number Publication Date
AR010583A1 true AR010583A1 (es) 2000-06-28

Family

ID=21858396

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP970105278A AR010583A1 (es) 1996-11-12 1997-11-12 CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN.
ARP060102014A AR053286A2 (es) 1996-11-12 2006-05-18 Cultivo de celulas de una cepa derivada de una cepa progenitra de una especie de neospora, vacuna que las contiene, metodos para preparar dicho cultivo, metodo para preparar una vacuna con dicho cultivo, metodo para vacunar un mamifero con dicha vacuna y vacuna que comprende dichas celulas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP060102014A AR053286A2 (es) 1996-11-12 2006-05-18 Cultivo de celulas de una cepa derivada de una cepa progenitra de una especie de neospora, vacuna que las contiene, metodos para preparar dicho cultivo, metodo para preparar una vacuna con dicho cultivo, metodo para vacunar un mamifero con dicha vacuna y vacuna que comprende dichas celulas

Country Status (16)

Country Link
US (3) US6656479B2 (es)
EP (1) EP0841392B1 (es)
JP (2) JP3690709B2 (es)
CN (2) CN1572322A (es)
AR (2) AR010583A1 (es)
AT (1) ATE271122T1 (es)
AU (1) AU733076B2 (es)
BR (1) BR9705473A (es)
CA (1) CA2220588C (es)
DE (1) DE69729839T2 (es)
DK (1) DK0841392T3 (es)
ES (1) ES2224210T3 (es)
NZ (1) NZ329095A (es)
PT (1) PT841392E (es)
TW (1) TW557214B (es)
ZA (1) ZA9710130B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
ES2281936T3 (es) 1997-10-20 2007-10-01 Bayer Corporation Vacuna contra neospora.
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
HUP0600049A3 (en) * 2001-10-31 2007-11-28 Pfizer Prod Inc Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
AU2004257939B2 (en) 2003-07-22 2008-06-05 Valneva Production of poxviruses with adherent or non adherent avian cell lines
WO2005063991A2 (en) * 2003-12-19 2005-07-14 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
NZ574678A (en) 2006-08-09 2012-03-30 Vivalis Method of production of transgenic avian using embryonic stem cells
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
CA3003343C (en) 2015-10-28 2024-05-28 Universidad Complutense De Madrid Neospora vaccine composition
BR112019006900A2 (pt) 2016-10-05 2019-07-02 Zoetis Services Llc métodos de liofilização que proporcionam protozoários desidratados estáveis para o uso como potentes vacinas vivas
AU2019276261A1 (en) 2018-05-30 2020-12-03 Institute For Research In Biomedicine Engineering B lymphocytes by utilizing endogenous activation-induced cytidine deaminase
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
EP0841392B1 (en) 2004-07-14
TW557214B (en) 2003-10-11
DE69729839T2 (de) 2005-07-21
ES2224210T3 (es) 2005-03-01
NZ329095A (en) 1998-03-25
CN1572322A (zh) 2005-02-02
CN1226406C (zh) 2005-11-09
US20060073157A1 (en) 2006-04-06
EP0841392A3 (en) 1999-03-24
AR053286A2 (es) 2007-04-25
ZA9710130B (en) 1999-06-10
DE69729839D1 (de) 2004-08-19
US6994861B2 (en) 2006-02-07
ATE271122T1 (de) 2004-07-15
JP3690709B2 (ja) 2005-08-31
PT841392E (pt) 2004-11-30
AU733076B2 (en) 2001-05-03
US6656479B2 (en) 2003-12-02
JPH10167983A (ja) 1998-06-23
DK0841392T3 (da) 2004-11-22
US20020044952A1 (en) 2002-04-18
JP2005230018A (ja) 2005-09-02
BR9705473A (pt) 1999-04-06
US20040062772A1 (en) 2004-04-01
CA2220588A1 (en) 1998-05-12
MX9708701A (es) 1998-09-30
CA2220588C (en) 2008-07-22
CN1190127A (zh) 1998-08-12
AU4520397A (en) 1998-05-14
JP3935180B2 (ja) 2007-06-20
EP0841392A2 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
AR010583A1 (es) CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN.
ES2184869T3 (es) Vacuna sub-unitaria contra la infeccion por flavivirus.
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
ES2065303T5 (es) Procedimiento de diagnosis y vacuna especifica.
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2089316T3 (es) Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
ES2150419T3 (es) Procedimiento de atenuacion bacteriana y vacuna.
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
CO4820445A1 (es) Expresion de proteina en sistemas de expresion del vector baculovirus
ES2155060T3 (es) Epitopos del virus de la hepatitis b incluidos en la respuesta de los linfocitos t citotoxicos (ctl) restringida para hla.
ES2132855T3 (es) Extracto de iridaceas y composiciones que lo contienen.
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
ECSP066916A (es) Vacuna contra estreptococo agalactiae
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
ES2051013T3 (es) Procedimiento de preparacion de compuesto ligando-receptor.
Camicas et al. Ecology of ticks as potential vectors of Crimean-Congo hemorrhagic fever virus in Senegal: epidemiological implications
ES2149759T3 (es) Vacuna contra la enfermedad de lyme.
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
PE72699A1 (es) Antigeno del rotavirus, vacuna y agente diagnostico para infeccion por rotavirus y un metodo para producir el antigeno
AR008491A1 (es) Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis
AR016396A1 (es) Homogeneizado preparado a partir de celulas de neospora, vacuna, procedimiento para prepararlo, equipo de vacunacion y anticuerpo.
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.
DE69836976D1 (de) Neospora impstoff
ES2058100T3 (es) Vacuna combinada.

Legal Events

Date Code Title Description
FG Grant, registration